- Home
- AIDX vs CHGA Comparison
AIDX vs CHGA Comparison
Compare AIDX & CHGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIDX | CHGA |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.0M |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AIDX | CHGA |
|---|---|---|
| Price | $0.23 | $1.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 129.2K | 63.8K |
| Earning Date | 11-15-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.48 | 33.18 |
| EPS | N/A | N/A |
| Revenue | ★ $2,045,133.00 | N/A |
| Revenue This Year | $44.20 | N/A |
| Revenue Next Year | $95.73 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 16.71 | N/A |
| 52 Week Low | $0.23 | $0.25 |
| 52 Week High | $18.96 | $3.02 |
Technical Indicators
Market Signals| Indicator | AIDX | CHGA |
|---|---|---|
| Relative Strength Index (RSI) | 24.29 | 41.05 |
| Support Level | N/A | $0.25 |
| Resistance Level | $0.69 | $2.54 |
| Average True Range (ATR) | 0.02 | 0.17 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 17.81 |
Price Performance
Historical ComparisonAbout AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
About CHGA Change Agents Corporation Common Stock
Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The company's current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, it is focused on delivering AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.